Brain Imaging in Differential Diagnosis of Dementia - Practical Neurology

Imaging biomarkers hold the promise of earlier diagnosis that may lead to more effective treatment.

Brain Imaging in Differential Diagnosis of Dementia Home Diseases & Diagnoses Imaging & Testing Back to Issue COVER FOCUS | JUN 2019 ISSUE Restart Program Play Program Media formats available: Text Download PDF Download Certificate View References Formats Choose a format Text Download PDF Introduction ß amyloid and phosphorylated tau proteins are pathologic hallmarks of Alzheimer’s disease (AD) that accumulate and spread predictably through distributed neural networks, causing progressive metabolic abnormalities, neuronal injury, and cellular death. Neuroimaging facilitates a detailed assessme

related reading

• Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review - PMCncbi.nlm.nih.gov
• Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status - PMCncbi.nlm.nih.gov
• Diffusion Tensor Imaging - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
• Using Interpretability to Identify a Novel Class of Alzheimer's Biomarkersgoodfire.ai
• Mining imaging and clinical data with machine learning approaches for the diagnosis and early detection of Parkinson’s disease | npj Parkinson's Diseasenature.com
• Gap Mapgap-map.org
• Biomarkers for Parkinson’s Disease: How Good Are They? - PMCpmc.ncbi.nlm.nih.gov
• Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study - PMCpmc.ncbi.nlm.nih.gov
• 'Breakthrough' blood test can find dementia risk before symptoms startnypost.com
• Pick Disease - StatPearls - NCBI Bookshelfncbi.nlm.nih.gov
• A quantitative spatial comparison of high-density diffuse optical tomography and fMRI cortical mapping - PMCncbi.nlm.nih.gov
• FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease | FDAfda.gov